These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group. Frei U, Taesch S, Niese D. Transplant Proc; 1994 Oct; 26(5):2928-31. PubMed ID: 7940925 [No Abstract] [Full Text] [Related]
25. Therapeutic equivalence and mg:mg switch ability of a generic cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients maintained on Sandimmun Neoral. Al Wakeel JS, Shaheen FA, Mathew MC, Abouzeinab HM, Al Alfi A, Tarif NM, Al Mousawi MS, Mahmoud TS, Alorrayed AS, Fagir EA, Dham RS, Shaker DS. Transplant Proc; 2008 Sep; 40(7):2252-7. PubMed ID: 18790206 [Abstract] [Full Text] [Related]
26. UK multicentre study to assess the safety and tolerability of Neoral in stable renal transplant patients. U.K. Neoral Study Group. Moore RH. Transplant Proc; 1996 Aug; 28(4):2202-3. PubMed ID: 8769200 [No Abstract] [Full Text] [Related]
28. Transfer of patients with kidney grafts to Sandimmun Neoral normalizes the calcium level in erythrocyts. Babarykin D, Amerika D, Adamsone I, Valinietse M, Rosental R. Transplant Proc; 1996 Dec; 28(6):3137. PubMed ID: 8962215 [No Abstract] [Full Text] [Related]
29. Safety and efficacy of conversion from once daily Sandimmun to twice daily Neoral cyclosporine in renal allograft recipients. Vathsala A, Lee WT, Lu YM, Woo KT. Transplant Proc; 1998 Aug; 30(5):1746-8. PubMed ID: 9723264 [No Abstract] [Full Text] [Related]
37. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH. Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413 [Abstract] [Full Text] [Related]